3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Barrett Esophagus
13
Esophageal Neoplasms
7
Rectal Neoplasms
6
Colorectal Neoplasms
6
Adenocarcinoma Of Esophagus
6
Nasopharyngeal Carcinoma
5
Stomach Neoplasms
4
Squamous Cell Carcinoma of Head and Neck
3
Polyps
3
Lung Neoplasms
3
Precancerous Conditions
2
Pathologic Complete Response
2
Hyperplasia
2
Gastroesophageal Reflux
2
Colorectal Neoplasms, Hereditary Nonpolyposis
2
Colonic Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Carcinoma
2
Adenomatous Polyposis Coli
2
Adenocarcinoma
2
Urogenital Neoplasms
1
Upper Tract Urothelial Carcinoma
1
Thyroid Neoplasms
1
Stomach Ulcer
1
Stomach Diseases
1
Recurrence
1
Polyposis, Gastric
1
Ovarian Neoplasms
1
Nasopharyngeal Neoplasms
1
Metaplasia
1
Interventions
Magnetic Resonance Spectroscopy
6
Dexamethasone
6
Cyclophosphamide
6
Blood Specimen Collection
6
Prednisone
5
Positron Emission Tomography Computed Tomography
4
Mammography
4
Lenalidomide
4
Colonoscopy
4
pembrolizumab
3
Tomography, X-Ray Computed
3
Surveys and Questionnaires
3
Melphalan
3
Exercise
3
Biopsy
3
2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid
3
weifuchun
2
obinutuzumab
2
fluciclovine F-18
2
daratumumab
2
carfilzomib
2
Preoperative Exercise
2
Positron-Emission Tomography
2
Methods
2
Magnetic Resonance Imaging
2
Injections
2
Gemcitabine
2
Educational Status
2
Doxorubicin
2
Cytarabine
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Disease
×
Endoscopy
×
Clear all
NCT07323186
2026-01-07
NEOTOGAS
Nantes University Hospital
Phase NA
Not yet recruiting
100 enrolled